PD-1 Blocker Safe in Childhood Cancers. But Does It Work?

PD-1-directed immunotherapy was safe and tolerable in children and adolescents with previously treated cancers, though responses were limited to those with lymphoma, a phase I/II study found.

Read more: https://www.medpagetoday.com/hematologyoncology/lymphoma/85497